Close
CDMO Safety Testing 2026
Novotech

News

Pharma Flip Payment Patent Settlements – EUGC Puts Last Pin

On October 18, 2023, the General Court of the European Union issued a judgement wherein it went on to reject the appeal made by Teva and Cephalon against the European Commission's decision from 2020. It is well to be...

Roquette Introduces New Chapter in Moisture Protection with Launch of Three New Excipient Grades at CPHI Barcelona

Roquette, a global leader in plant-based ingredients and leading provider of pharmaceutical and nutraceutical excipients,ย is pleased to announce the addition of three new excipient grades to its unmatched portfolio of solutions for moisture sensitive active pharmaceutical and nutraceutical ingredients....

Combining local knowledge, expertise and full service support with a complete product portoflio targeted to the Indian pharmaceutical industry

The CPHI & PMEC India 2023 edition, the platform where international and domestic pharma experts meet to do business, network and shape the future of the pharmaceutical industry in India and South East Asia, will soon be back in...

Roche – Biogen Settle US Patent Law Suit For Arthritis Drug

Based on a filing on October 23 in Massachusetts federal court, Roche, the Swiss pharmaceutical giant, has reached a settlement in a patent lawsuit against Biogen, which happens to be a U.S. biotech firm. The lawsuit was concerning Biogen's...

Draft Pandemic Accord Has IP Waivers, Pathogen Sharing Perks

The draft pandemic accord, which was sent to member states of the World Health Organisation by the Intergovernmental Negotiating Body recently, includes several important elements. One of these is the provision for time-bound waivers when it comes to intellectual...

Greater Pharma & Tech COs Ties Can Drive Innovation Further

Big tech along withย Big Pharma have gone on to playย a crucial role in elevating standards of living as well as shaping the modern age. Over the course of several decades, both big pharma and big tech have heavily relied on...

CDMO-Biotech Collab Diminish Business Risk In Drug Creation

Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high costs, complicated manufacturing processes, as well as regulatory hurdles related to biologics can go on...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป